"We have shown for the first time that immediate treatment after a first clinical demyelinating event suggestive of MS can reduce the early neurological damage, which may ultimately delay the development of the debilitating sequelae that characterize adv
Rituxan cancer drug proved highly effective against multiple sclerosis in a small mid-stage trial, signaling a potentially more effective way of treating the progressive neurological disease.
An abundance of vitamin D seems to help prevent multiple sclerosis, according to a study in more than 7 million people that offers some of the strongest evidence yet of the power of the "sunshine vitamin" against MS.
European Journal of Neurology (EJN) reports a study1 which shows that Sativex, a cannabis based medicine, significantly reduces intractable spasms and stiffness (spasticity) in people with Multiple Sclerosis
But there is evidence that MS goes into remission when women become pregnant, and in some cases the body actually begins to repair some of the damage.
In patients with recently diagnosed multiple sclerosis, the extent of accumulated brain tissue loss and overall lesion load as determined by magnetic resonance imaging (MRI) may predict the rate of cerebral atrophy over the following two years, according
When more than one member of a family is affected by multiple sclerosis (MS), their ages at disease onset are likely to be similar, but disease severity may not be.
Conducting a study on mice, researchers from the Gulbenkian Institute in Portugal have shown that an increased expression of a protein called HO-1, and administration of carbon monoxide, protect the animal from Multiple sclerosis (MS).
An invitation-only stem cell summit is taking place in San Francisco this week, with the world's top scientists gathered to discuss the promise of stem cell research in multiple sclerosis.
The first study examining the relationship between parasite infections and multiple sclerosis in humans suggests that such infections may affect the immune response in a way that alters the course of MS.
People with multiple sclerosis are backing a Norfolk and Norwich University Hospital study into whether cannabis will help them cope with the condition.
The Roskamp Institute announced today its participation in a pharmaceutical sponsored research study for relapsing-remitting Multiple Sclerosis (MS) sufferers.
The study, to be published in the Dec. 3 advance online edition of Nature Immunology, lays the groundwork for a way to determine when a relapse is about to occur, and could eventually lead to a treatment to prevent relapses.
